Desai, P.P.; Narra, K.; James, J.D.; Jones, H.P.; Tripathi, A.K.; Vishwanatha, J.K.
Combination of Small Extracellular Vesicle-Derived Annexin A2 Protein and mRNA as a Potential Predictive Biomarker for Chemotherapy Responsiveness in Aggressive Triple-Negative Breast Cancer. Cancers 2023, 15, 212.
https://doi.org/10.3390/cancers15010212
AMA Style
Desai PP, Narra K, James JD, Jones HP, Tripathi AK, Vishwanatha JK.
Combination of Small Extracellular Vesicle-Derived Annexin A2 Protein and mRNA as a Potential Predictive Biomarker for Chemotherapy Responsiveness in Aggressive Triple-Negative Breast Cancer. Cancers. 2023; 15(1):212.
https://doi.org/10.3390/cancers15010212
Chicago/Turabian Style
Desai, Priyanka P., Kalyani Narra, Johanna D. James, Harlan P. Jones, Amit K. Tripathi, and Jamboor K. Vishwanatha.
2023. "Combination of Small Extracellular Vesicle-Derived Annexin A2 Protein and mRNA as a Potential Predictive Biomarker for Chemotherapy Responsiveness in Aggressive Triple-Negative Breast Cancer" Cancers 15, no. 1: 212.
https://doi.org/10.3390/cancers15010212
APA Style
Desai, P. P., Narra, K., James, J. D., Jones, H. P., Tripathi, A. K., & Vishwanatha, J. K.
(2023). Combination of Small Extracellular Vesicle-Derived Annexin A2 Protein and mRNA as a Potential Predictive Biomarker for Chemotherapy Responsiveness in Aggressive Triple-Negative Breast Cancer. Cancers, 15(1), 212.
https://doi.org/10.3390/cancers15010212